NIH studying promising antibody treatment for MIS-C
Researchers from the National Institutes of Health say they are studying a promising antibody treatment for multisystem inflammatory syndrome in children, or MIS-C.
Nearly two-thirds of Americans have at least 1 dose of COVID-19 vaccine
This equates to more than 220 million people — 66.5% — with at least one shot against the deadly coronavirus.
CDC: Some immunocompromised people may need 4th COVID-19 vaccine dose
People who are moderately or severely immunocompromised may receive a fourth COVID-19 vaccine dose, according to updated CDC guidance.
Merck to share license for COVID-19 pill with other drugmakers to expand access
Merck agreed to allow other drugmakers to produce its COVID-19 pill, in an effort to help people in poorer countries get access to the drug.
FDA panel endorses Pfizer’s COVID-19 vaccine for children 5-11
An FDA panel of outside vaccine experts endorsed kid-sized doses of Pfizer’s COVID-19 vaccine for U.S. children aged 5 to 11.
Moderna to supply Africa with up to 110 million COVID-19 vaccine doses
Moderna said it will make up to 110 million doses of its COVID-19 vaccine available to African countries at its “lowest tiered price.”
Moderna says COVID-19 vaccine generates 'robust' response in kids 6-11
Moderna’s COVID-19 vaccine generated a “robust” neutralizing antibody response in children ages 6 to 11, the company said Monday.
DeSantis: We are actively recruiting out-of-state police officers out of job due to vaccine mandates
The Republican governor slammed the 'unconstitutional' mandates.
US unemployment claims fall to 290,000, a new pandemic low
Unemployment claims in the U.S. reached another pandemic low last week, declining to 290,000.
FDA approves mixing COVID-19 vaccines for boosters
Dr. Peter Hotez, with Baylor College of Medicine, tells FOX 26, a third dose is needed for those who received the Pfizer and Moderna vaccine, and recommends sticking with the same vaccine.
FDA approves mixing of vaccine doses
FOX 26 Reporter Tiffany Justice spoke with Dr. Peter Hotez about the FDA announcement that was made on Wednesday regarding mixing vaccine doses.
Interferon does not help hospitalized COVID-19 patients, NIH study finds
A recent National Institutes of Health trial published on Monday highlights the failure of a COVID-19 treatment known as interferon beta-1a, a medicine with both antiviral and anti-inflammatory properties.
Gates Foundation to spend $120M on access to Merck’s antiviral COVID-19 pill
The Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets approved by regulators.
Arkansas restaurant pays student employees to do homework during shift
A restaurant group in Arkansas is allowing student employees to do homework for an hour while on the clock, an initiative that is raising grades and also recruiting more employees amid the country’s labor shortage.
Colin Powell, former US secretary of state, dies of COVID-19 complications
Colin Powell, former U.S. Joint Chiefs chairman and secretary of state, has died due to complications from COVID-19.
Preparing students for college during pandemic
Local counselor helps high school students prepare for the transition to college during the pandemic.
September was worst month for child COVID-19 infections, AAP says
The American Academy of Pediatrics also said the overall COVID-19 infection rate is 8,035 cases per 100,000 children in the population.
How have churches navigated during the pandemic?
Two pastors join The Factor to discuss how the pandemic has impacted their churches and congregations.
J&J COVID-19 booster: FDA panel endorses extra dose at least 2 months later
An FDA panel on Friday voted to recommend a booster dose of the single-shot Johnson & Johnson COVID-19 vaccine at least two months later.
Italy's mandatory COVID-19 pass for all workers prompts protests
All workers across public and private sectors in Italy are required to show a COVID-19 health pass to get into their place of employment.